Literature DB >> 7493537

Evaluation of the range of areas of the fluorescein staining patterns of the tarsal conjunctiva in man.

M J Doughty1, R Potvin, N Pritchard, D Fonn.   

Abstract

Fluorescein dye is commonly used to highlight the tarsal conjunctiva in man to facilitate diagnosis of papillary conjunctivitis. A quantitative analysis of the fluorescein-highlighted features could be useful in both assignment of severity grades as well as for objective comparisons but no data is available on the distributions of sizes (areas) of these features. An exploratory, range-finding study was undertaken to provide data on feature areas that might be encountered. After application of fluorescein, 35 mm photographs were taken at a fixed distance with zone 1/zone 2 (Allansmith) of the tarsal plate aligned perpendicular to the camera. The photographs were projected, an overlay of 150 to 180 contiguous features outlined by fluorescein made and planimetry used to assess the areas and area distributions of the features on tarsal plates clinically graded with stages 1 to 4 papillary hypertrophy. For zone 1 of the tarsal plate in asymptomatic subjects, a fluorescein solution highlights the limits of features that enclose an area averaging 30,000 microns2 (range 8000 to 120,000; median area of close to 35,000 microns2). The areas of these features were generally normally distributed and there was little variation in feature areas across the zone. At different stages of clinical papillary conjunctivitis, the areas of the negative staining patterns are larger. Averages of 60,000 to 90,000 microns2, median values of close to 70,000 microns2 and individual feature areas up to 350,000 microns2 were seen in mildly symptomatic patients. These distributions were generally heterogeneous and showed a skewed distribution. Areas averaging up to 0.755 mm2 (range 0.6 to 3.2 mm2) were measured in moderate to severe papillary hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7493537     DOI: 10.1007/bf01203711

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  9 in total

Review 1.  Giant papillary conjunctivitis.

Authors:  M R Allansmith
Journal:  J Am Optom Assoc       Date:  1990-06

2.  Surface morphology of the human upper tarsal conjunctiva.

Authors:  J V Greiner; H I Covington; M R Allansmith
Journal:  Am J Ophthalmol       Date:  1977-06       Impact factor: 5.258

3.  Giant papillary conjunctivitis in contact lens wearers.

Authors:  M R Allansmith; D R Korb; J V Greiner; A S Henriquez; M A Simon; V M Finnemore
Journal:  Am J Ophthalmol       Date:  1977-05       Impact factor: 5.258

4.  Extended wear of Hydrocurve II55 soft contact lenses.

Authors:  J P Miller; L J Coon; R F Meier
Journal:  J Am Optom Assoc       Date:  1980-03

Review 5.  CCLRU standards for success of daily and extended wear contact lenses.

Authors:  R L Terry; C M Schnider; B A Holden; R Cornish; T Grant; D Sweeney; D La Hood; A Back
Journal:  Optom Vis Sci       Date:  1993-03       Impact factor: 1.973

Review 6.  Conjunctivitis of allergic origin: clinical presentation and differential diagnosis.

Authors:  M H Friedlaender
Journal:  Surv Ophthalmol       Date:  1993 Jul-Aug       Impact factor: 6.048

7.  Biomicroscopy of papillae associated with hard contact lens wearing.

Authors:  D R Korb; M R Allansmith; J V Greiner; A S Henriquez; J P Herman; P P Richmond; V M Finnemore
Journal:  Ophthalmology       Date:  1981-11       Impact factor: 12.079

8.  Pathology and treatment of giant papillary conjunctivitis. I. The U.S. perspective.

Authors:  M R Allansmith
Journal:  Clin Ther       Date:  1987       Impact factor: 3.393

9.  Giant papillary conjunctivitis induced by hard or soft contact lens wear: quantitative histology.

Authors:  M R Allansmith; D R Korb; J V Greiner
Journal:  Ophthalmology       Date:  1978-08       Impact factor: 12.079

  9 in total
  1 in total

1.  Incremental nature of anterior eye grading scales determined by objective image analysis.

Authors:  J S Wolffsohn
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.